$BIM #bioMerieux S.A. bioMerieux : One of the precious few “COVID-19 plays”: &gt;A serological test in the summer (and a comprehensive) range - Primarily themed on the coronavirus crisis, the highlights from conference call, as we see it,… https://t.co/ywfOhglIjX #equity #stocks https://t.co/qghiIr0Ln5